Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through three segments: Direct Offices, International Licensees, and Education Practice. It also provides a suite of individual-effectiveness and leadership-development training and products. The company was incorporated in 1983 and is headquartered in Salt Lake City, Utah.

Franklin Covey Co.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SALT LAKE CITY--(BUSINESS WIRE)--FRANKLIN COVEY CO. (NYSE: FC), A LEADER IN ORGANIZATIONAL PERFORMANCE IMPROVEMENT THAT CREATES AND DISTRIBUTES WORLD-CLASS SOLUTIONS, INCLUDING CONTENT, TRAINING, PROCESSES, AND TOOLS THAT ORGANIZATIONS AND INDIVIDUALS USE TO ACHIEVE SYSTEMIC CHANGES IN HUMAN BEHAVIOR TO TRANSFORM THEIR RESULTS, TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS APPROVED REPLENISHING THE COMPANY'S AUTHORIZATION TO REPURCHASE UP TO AN AGGREGATE AMOUNT OF $50 MILLION OF ITS OUTSTANDI.

FRANKLIN COVEY CO. ANNOUNCES REPLENISHMENT OF SHARE REPURCHASE PROGRAM UP TO $50 MILLION AND ADOPTION OF RULE 10B5-1 TRADING PLAN

SOUTH SAN FRANCISCO, CALIF., AUG. 01, 2025 (GLOBE NEWSWIRE) -- ALLOGENE THERAPEUTICS, INC.(NASDAQ: ALLO), A CLINICAL-STAGE BIOTECHNOLOGY COMPANY PIONEERING THE DEVELOPMENT OF ALLOGENEIC CAR T (ALLOCAR T) PRODUCTS FOR CANCER AND AUTOIMMUNE DISEASE, TODAY ANNOUNCED THAT IT HAS SELECTED STANDARD FLUDARABINE AND CYCLOPHOSPHAMIDE (FC) AS THE LYMPHODEPLETION REGIMEN TO BE USED IN ITS ALPHA3 STUDY EVALUATING CEMACABTAGENE ANSEGEDLEUCEL (CEMA-CEL) IN FIRST-LINE CONSOLIDATION FOR LARGE B-CELL LYMPHOMA (LBCL). THIS LYMPHODEPLETION REGIMEN SELECTION WAS MADE IN CONJUNCTION WITH THE ALPHA3 DATA AND SAFETY MONITORING BOARD (DSMB) AND STEERING COMMITTEE AND FOLLOWING CONSULTATION WITH THE U.S. FOOD AND DRUG ADMINISTRATION (FDA).

ALLOGENE THERAPEUTICS MOVES FORWARD WITH STANDARD FLUDARABINE AND CYCLOPHOSPHAMIDE (FC) LYMPHODEPLETION REGIMEN IN THE ALPHA3 TRIAL FOR CEMACABTAGENE ANSEGEDLEUCEL (CEMA-CEL) IN FIRST-LINE CONSOLIDATION FOR LARGE B-CELL LYMPHOMA

SALT LAKE CITY--(BUSINESS WIRE)--FRANKLIN COVEY CO. (NYSE: FC), A LEADER IN ORGANIZATIONAL PERFORMANCE IMPROVEMENT THAT CREATES AND DISTRIBUTES WORLD-CLASS CONTENT, TRAINING, PROCESSES, AND TOOLS THAT ORGANIZATIONS AND INDIVIDUALS USE TO ACHIEVE SYSTEMIC CHANGES IN HUMAN BEHAVIOR TO TRANSFORM THEIR RESULTS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD FISCAL 2025 QUARTER, ENDED MAY 31, 2025. THIRD QUARTER FISCAL 2025 FINANCIAL RESULTS THE COMPANY'S CONSOLIDATED REVENUE FOR Q3 FY2025 WAS.

FRANKLIN COVEY REPORTS THIRD QUARTER FISCAL 2025 FINANCIAL RESULTS

/NOT FOR DISTRIBUTION OVER U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, JUNE 19, 2025 (GLOBE NEWSWIRE) -- FIRM CAPITAL MORTGAGE INVESTMENT CORPORATION (THE CORPORATION) (TSX: FC) TODAY ANNOUNCED THAT AT THE ANNUAL AND SPECIAL MEETING (THE MEETING) OF SHAREHOLDERS OF THE CORPORATION HELD EARLIER TODAY, ALL DIRECTOR NOMINEES WERE ELECTED AS DIRECTORS OF THE CORPORATION, AS FOLLOWS: NOMINEE VOTES FOR % VOTES FOR VOTES AGAINST % OF VOTES AGAINST GEOFFREY BLEDIN 7,644,314 98.20%  139,787 1.80%  ELI DADOUCH 7,715,534 99.12%  68,567 0.88%  MORRIS FISCHTEIN 7,662,671 98.44%  121,430 1.56%  STANLEY GOLDFARB 7,648,442 98.26%  135,659 1.74%  VICTORIA GRANOVSKI 7,667,410 98.50%  116,691 1.50%  ANTHONY HELLER 7,572,084 97.28%  212,017 2.72%  JONATHAN MAIR 7,665,597 98.48%  118,504 1.52%  HON. FRANCIS NEWBOULD 7,696,345 98.87%  87,756 1.13%  HON.

FIRM CAPITAL MORTGAGE INVESTMENT CORPORATION ANNOUNCES ELECTION OF DIRECTORS

SALT LAKE CITY--(BUSINESS WIRE)--FRANKLIN COVEY CO. (NYSE: FC), A LEADER IN ORGANIZATIONAL PERFORMANCE IMPROVEMENT, ANNOUNCED TODAY THAT THE CONFERENCE CALL TO REVIEW THE COMPANY'S THIRD QUARTER FISCAL 2025 FINANCIAL RESULTS WILL TAKE PLACE ON WEDNESDAY, JULY 2, 2025, AT 5:00 P.M. ET (3:00 P.M. MT). THE COMPANY'S FINANCIAL RESULTS ARE EXPECTED TO BE RELEASED AFTER THE CLOSE OF THE MARKET ON WEDNESDAY, JULY 2, 2025. INTERESTED PERSONS MAY ACCESS A LIVE WEBCAST HTTPS://EDGE.MEDIA-SERVER.COM/MMC/P.

FRANKLIN COVEY TO REPORT THIRD QUARTER FISCAL 2025 RESULTS

SALT LAKE CITY--(BUSINESS WIRE)-- #BEHAVIORCHANGE--FRANKLINCOVEY APPOINTS DARIUSZ PACZUSKI AS CHIEF MARKETING OFFICER.

FRANKLINCOVEY APPOINTS DARIUSZ PACZUSKI AS CHIEF MARKETING OFFICER

SALT LAKE CITY--(BUSINESS WIRE)-- #AGILITY--FRANKLINCOVEY HOSTS EXCLUSIVE LIVE WEBINAR WITH BESTSELLING AUTHORS, AMY EDMONDSON, STEPHEN M.R. COVEY AND LIZ WISEMAN: LEADERSHIP IN UNCERTAIN TIMES.

FRANKLINCOVEY HOSTS EXCLUSIVE LIVE WEBINAR WITH BESTSELLING AUTHORS, AMY EDMONDSON, STEPHEN M. R. COVEY AND LIZ WISEMAN ON THE POWER OF LEADERSHIP IN UNCERTAIN TIMES

SALT LAKE CITY--(BUSINESS WIRE)-- #BEHAVIORCHANGE--TRAINING INDUSTRY NAMES FRANKLINCOVEY AS A 2025 TOP 20 LEADERSHIP TRAINING COMPANY FOR THE 15TH TIME.

TRAINING INDUSTRY NAMES FRANKLINCOVEY AS A 2025 TOP 20 LEADERSHIP TRAINING COMPANY FOR THE 15TH TIME

SALT LAKE CITY--(BUSINESS WIRE)-- #1ON1COACHING--FRANKLINCOVEY LAUNCHES THE FRANKLINCOVEY COACHING SUITE: THE RESULTS-FOCUSED DATA-DRIVEN OFFERING ACCELERATES LEADERSHIP IMPACT ACROSS ORGANIZATIONS.

FRANKLINCOVEY LAUNCHES THE FRANKLINCOVEY COACHING SUITE, A RESULTS-FOCUSED DATA-DRIVEN OFFERING WHICH ACCELERATES LEADERSHIP IMPACT ACROSS ORGANIZATIONS

SALT LAKE CITY--(BUSINESS WIRE)-- #BEHAVIORCHANGE--FRANKLINCOVEY PARTNERS WITH BESTSELLING AUTHORS, JAMES PATTERSON AND DR. PATRICK LEDDIN, TO EQUIP LEADERS TO NAVIGATE DISRUPTION, BASED ON NEW BOOK.

FRANKLINCOVEY PARTNERS WITH BESTSELLING AUTHORS, JAMES PATTERSON AND DR. PATRICK LEDDIN, TO EQUIP LEADERS TO NAVIGATE DISRUPTION, BASED ON THEIR HIGHLY ANTICIPATED BOOK, DISRUPT EVERYTHING

Franklin Covey Co.

FC

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Franklin Covey Co.

FC.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

FC